The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | International perspectives on the management of CLL and the Lymphoma Coalition Global Patient Survey
Natacha Bolaños, Lymphoma Coalition Europe, Madrid, Spain, discusses a session focused on addressing global inequalities and improving the patient experience for patients with chronic lymphocytic leukemia (CLL). She mentions barriers to diagnosis, treatment, and clinical trials. Ms Bolaños also highlights the work of the Lymphoma Coalition Global Patient Survey, speaks about the importance of assessing patients’ quality of life, and mentions how communication between physicians and patients can be improved. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
